MARY JANE LAARNI ALAMARES: Open Payments
NPI 1528646320 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 22 payments from 12 companies in 2025. Trend: 2023 $252 · 2024 $348 · 2025 $577
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 1 | $120 |
| Lilly USA, LLC | 3 | $83 |
| Calliditas Therapeutics US Inc. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Fresenius USA Marketing, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $39 |
| Vifor Pharma, Inc. | 2 | $38 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $19 |
Products named: JARDIANCE, Vafseo, TARPEYO, Kerendia, VELPHORO, Veltassa, KRYSTEXXA, IBSRELA.
Industry payments across PA — which companies pay providers there.
